Overview

Efficacy of Suvorexant in the Treatment of Insomnia in Midlife Women With Pre-Diabetes

Status:
Not yet recruiting
Trial end date:
2024-09-30
Target enrollment:
Participant gender:
Summary
The aim of this study is to determine if suvorexant can help treat the severity of insomnia in midlife women who are pre-diabetic.
Phase:
Phase 4
Details
Lead Sponsor:
Brigham and Women's Hospital
Treatments:
Suvorexant